Aguirre Jarrad Mattieu insider trades
Aguirre Jarrad Mattieu has filed 2 Form 4s with the SEC that we hold, all for Lyell Immunopharma, Inc. (LYEL), as Chief Medical Officer. Across all of them we count 0 purchases worth $0 and 1 sale worth $3.6K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($3.6K). The largest single trade was a sale of 422 shares of Lyell Immunopharma, Inc. worth $3.6K, dated 2026-10-12. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2026-09-10 and the latest 2026-10-13.
Lyell Immunopharma, Inc. (LYEL)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-10-12 | S, sale reported on Form 4 | 422 | $3.6K | 2026-10-13 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 2150331) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
